Genetron Health Reports Unaudited First Quarter 2022 Financi

02.06.2022 - BEIJING, June 02, 2022 (GLOBE NEWSWIRE) - Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer ...

Related Keywords

China , Beijing , United States , Hong Kong , American , Edmond Lococo , Onco Panscan , Sizhen Wang , Yanrong Zhao , Exchange Rate Information , Company Nasdaq , Company Seq , Owners Of The Company , Principal Gilmartin Group , American Association For Cancer Research , Genetron Holdings , Genetron Holdings Limited Health , Genetron Health , Fusionscan Plus , One Step Seq , Translational Medicine , Mutation Capsule , Lung Cancer Assay , American Association , Cancer Research , Annual Meeting , Holdings Limited , Securities Litigation Reform Act ,